Metrics as of 10/13/2026, 06:54 PM (Berlin time), refresh in progress.
Neonc Technologies Holdings Stock
Neonc Technologies Holdings, Inc.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Amir Farrokh Heshmatpour
- Employees
- 5
- Market cap
- $67 M
- IPO
- 26/03/2025
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.
Neonc Technologies Holdings stock: price history
1D
-4.8%
1W
-13.0%
1M
-29.3%
6M
-51.8%
YTD
-68.6%
1Y
-77.0%
2Y
–
5Y
–
10Y
–
Next earnings date
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~42% stronger price swings than usual
Ask the agents about Neonc Technologies Holdings
Analyst assessment of Neonc Technologies Holdings
PRICE TARGET LOW
US$13.00
CONSENSUS
US$16.00
MEDIAN
US$15.00
PRICE TARGET HIGH
US$20.00
0
STRONG BUY
1
BUY
0
HOLD
0
SELL
0
STRONG SELL
1
TOTAL · Buy
As of: 08/09/2026
Neonc Technologies Holdings stock metrics
P/E
-1.17
P/B
-3.45
EV/EBITDA
-1.5
RETURN ON EQUITY
76.9%
NET MARGIN
0.0%
DEBT/EQUITY
-0.02
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
22.1%
FLOAT SHARES
5,718,125
AVG. DAILY VOLUME (30D)
194,600
Insider transactions (SEC)
GARNETT KEITHLY
Heshmatpour Amir F
Heshmatpour Amir F
GARNETT KEITHLY
CHEN THOMAS C
Institutional holders
Comparable stocks
Frequently asked questions about Neonc Technologies Holdings stock
What does Neonc Technologies Holdings do?
Neonc Technologies Holdings, Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Amir Farrokh Heshmatpour, the company employs around 5 people.
The IPO was on 26/03/2025; the stock trades on NASDAQ under the ticker NTHI.
What do analysts say about Neonc Technologies Holdings stock?
1 analysts rate the stock, the consensus is Buy (as of 08/09/2026).
The average price target is US$16.00, ranging from US$13.00 to US$20.00, with a median of US$15.00.
This is an external assessment, not a statement by Market Jury.
When does Neonc Technologies Holdings report next?
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly 42% stronger than usual.
Does Neonc Technologies Holdings pay a dividend?
No, Neonc Technologies Holdings currently does not pay a dividend.
Which stocks are comparable to Neonc Technologies Holdings?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get Neonc Technologies Holdings stock analyzed?
Clicking "Analyze stock" lets five strategies assess Neonc Technologies Holdings against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.